The potential use of psychedelic-assisted therapy for adolescents with mental illness has sparked both interest and concern. Modern psychedelic resear…

Leading health law expert Barry R. Furrow of Drexel University and Yale bioethics specialist Stephen R. Latham discussed what happens when private equity comes for hospice care.

This mixed-methods study examines variation in US state-level policies regarding the oversight and regulation of intravenous hydration spas as well as their product offerings, claims, and practices.

This study uses the NHANES database to describe clinical characteristics of Medicaid beneficiaries at risk of disenrollment due to the One Big Beautiful Bill Act’s (HR 1) work requirements, stratified...

Background The clinical and economic impact of breast cancer screening varies based on the modality, frequency, and age of the screened population. Objective To characterize changes in use and cost of breast cancer screening for older women. Design Serial cross-sectional study using data from SEER-Medicare, 2009–2019. Participants Women 67 and older enrolled in Medicare fee-for-service. Main Measures Screening use and cost by age, frequency, and modality. We further categorized screening as cost-effective or cost-ineffective based on published economic analyses rather than guidelines. Cost-effective screening included biennial mammography among women < age 80, while cost-ineffective screening included annual mammography, addition of digital breast tomosynthesis (DBT), screening ultrasound, and any screening among women 80 and older. We estimated total annual spending on screening in Medicare fee-for-service, inflated to 2019 dollars. Key Results Our sample included a mean of 229,683 (range 222,400- 244,793) Medicare beneficiaries annually. Biennial screening was stable among women 65–79, at 11.2% (95% CI 11.0–11.4) in 2009 and 11.9% (95% CI 11.7–12.0) in 2019. Annual screening was also stable at 32.5% (95% CI 32.3–32.7) in 2009 and 30.0% (95% CI 29.8–30.2) in 2019. Among women 80 and older, screening (annual or biennial) declined from 19% (95% CI 18.8–19.3) to 12.9% (95% CI 12.7–13.2). Between 2009–2019, use of DBT rose from 0% to 70.3% of screened women. Total spending on cost-effective screening rose from $569 million per year to $735 million per year, a 29% increase. Spending on cost-ineffective screening rose from $548 million to $1.025 billion, an 87% increase. By 2019, spending on cost-ineffective screening accounted for 58% of total spending. Conclusions Screening costs for older women have risen, driven by expenditures on technologies that may not be cost-effective. Reducing use of low value screening could result in savings that could be reallocated toward high value screening and follow up testing.

Industry reports indicate that small biopharmaceutical companies are increasingly launching their own new molecular entities, with first-time companies expected to represent the primary share of bloc...

YSPH has developed two innovative approaches for studying public health and translating the school's research into community impact across Connecticut.

As the CDC walks back vaccine recommendations, states are considering a broad set of strategies to ensure vaccine access.

NFL injury lists began after a high-rolling gambler learned five players on one team had the flu. It’s time to change the system.

In this brief, we estimate the impact on coverage of the expiration of enhanced PTCs that would occur in 2026 without action by Congress. Our estimates inclu…

America's go-to response for combating elder abuse and exploitation may even put older adults at further risk. Here is how communities can shift strategies.

Yale Law School students, through a Solomon Center collaboration, helped prepare a guide for families to prepare for immigration enforcement.

OBJECTIVE. Feeling prepared for a child’s end of life (EOL) may help to alleviate parents’ psychological symptoms following their child’s death from cancer. However, most parents report feeling unprep...

The University of Washington School of Law welcomes new members of our faculty in the 2025–2026 academic year.

Objective To examine a 2018 rule change allowing pediatric providers to bill the child’s Medicaid ID for post-partum depression (PPD) screening of mothers conducted during well-child visits, and docum...

Cohen spoke about the challenges and opportunities for public health and health care in a period of major policy change.

Joining a state advisory committee, Solomon Center researchers offer bold solutions to improve health outcomes for children with serious illnesses.

AgeTech is enabling older adults to live at home for longer than ever before. But there's a hidden cost: unprecedented surveillance, including by their own families

Researchers at the Solomon Center for Health Law and Policy recommend ways that access to palliative care can be improved for Connecticut’s estimated 7,000+ children living with serious illnesses.

By easing pain, anxiety, and other symptoms, palliative care allows children to participate in family activities, school, and favorite pursuits to a much greater degree than would otherwise be poss…

Professor Claudia E. Haupt, a nationally recognized expert on First Amendment law whose current work is situated at the intersection of free speech, health and technology, has been named faculty co-di...

Last month's Manhattan tower shooter was subject to multiple emergency holds after he was deemed to be dangerous to himself and others. So why was he able to own a gun?

This survey study including substance use disorder experts used a Delphi consensus process to develop best-practice recommendations for addressing patients’ in-hospital substance use.